Komori
Daito Chemix (4366) · RiskRestated

Market Price Risk on Investment Securities

First written in FY2019. 15 of 16 entries say "Restated". Latest entry: FY2026-H1.

16entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019 – FY2026-H12019: 320192020: 320202021: 220212022: 320222023: 320232024: 120242025: 12025
Same theme, other companies
Market price fluctuation risk of financial instruments heldA theme 316 companies write about · 315 as a headwind · 2 as a tailwind

The whole theme swung hardest in 2019: 53 of 135 companies on the "Worse" side.

60 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 319 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「During the interim consolidated accounting period, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    投資有価証券の市場価格変動リスクについて、新たな発生や重要な変更はないとしている。
  2. FY2024-Q3RestatedAnnual report

    「During the cumulative consolidated period for the third quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    投資有価証券の市場価格変動リスクについて、新たな発生や重要な変更はないとしている。
  3. FY2024-Q2RestatedAnnual report

    「During the cumulative consolidated period for the second quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    投資有価証券の市場価格変動リスクについて、新たな発生や重要な変更はないとしている。
  4. FY2023RestatedAnnual report

    「Investment securities consist mainly of shares in companies with which the Company has business relationships and are exposed to the risk of fluctuations in market prices.」

    政策保有株式等の市場価格変動リスクと、四半期ごとの時価・財務状況把握を継続している。
  5. FY2023-Q3RestatedAnnual report

    「During the cumulative consolidated period for the third quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    投資有価証券の市場価格変動リスクについて、新たな発生や重要な変更はないとしている。
  6. FY2023-Q2RestatedAnnual report

    「During the cumulative consolidated period for the second quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    投資有価証券の市場価格変動リスクについて、新たな発生や重要な変更はないとしている。
  7. FY2023-Q1RestatedAnnual report

    「During the cumulative consolidated period for the first quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    投資有価証券の市場価格変動リスクについて、新たな発生や重要な変更はないとしている。
  8. FY2022-Q3RestatedAnnual report

    「During the cumulative consolidated period for the third quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    投資有価証券の市場価格変動リスクについて、新たな発生や重要な変更はないとしている。
  9. FY2022-Q1RestatedAnnual report

    「During the cumulative consolidated period for the first quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    投資有価証券の市場価格変動リスクについて、新たな発生や重要な変更はないとしている。
  10. FY2021-Q3RestatedAnnual report

    「During the cumulative consolidated period for the third quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    投資有価証券の市場価格変動リスクについて、新たな発生や重要な変更はないとしている。
  11. FY2021-Q2RestatedAnnual report

    「During the cumulative consolidated period for the second quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    投資有価証券の市場価格変動リスクについて、新たな発生や重要な変更はないとしている。
  12. FY2021-Q1RestatedAnnual report

    「During the cumulative consolidated period for the first quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    投資有価証券の市場価格変動リスクについて、新たな発生や重要な変更はないとしている。
  13. FY2020RestatedAnnual report

    「Investment securities consist mainly of shares in companies with which the Company has business relationships and are exposed to the risk of fluctuations in market prices.」

    政策保有株式等の市場価格変動リスクを継続している。
  14. FY2020-Q2RestatedAnnual report

    「During the cumulative consolidated period for the second quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」

    投資有価証券の市場価格変動リスクについて、新たな発生や重要な変更はないとしている。
  15. FY2020-Q1RestatedAnnual report

    「During the cumulative first quarter, there were no newly arising business or other risks. There were also no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    投資有価証券の市場価格変動リスクについて、新たな発生や重要な変更はないとしている。
  16. FY2019First statedAnnual report

    「Investment securities consist mainly of shares in companies with which the Company has business relationships and are exposed to the risk of fluctuations in market prices.」

    業務上の関係を有する企業の株式を保有し、市場価格の変動リスクに晒されていることを記載している。四半期ごとの時価・財務状況の把握と取締役会への報告も行っている。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Daito Chemix's next results are scheduled for 2026-10-29. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.